A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [(18)F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer

PURPOSE: We conducted a pilot trial utilizing [(18)F]FMAU [1-(2′-deoxy-2′-[(18)F]fluoro-β-d-arabinofuranosyl thymine] as a tumor tracer in positron emission tomography (PET) and evaluated its reproducibility, and changes in maximum and peak standardized uptake value (SUVmax and SUVpeak) with zoledro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Imaging Biol
Auteurs principaux: Vaishampayan, Ulka N., Tehrani, Omid S., Lawhorn-Crews, Jawana M., Heilbrun, Lance K., Dobson, Kimberlee, Smith, Daryn, Dickow, Brenda, Shields, Anthony F.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6844072/
https://ncbi.nlm.nih.gov/pubmed/28289967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-017-1057-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires